Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing-Reference-Cited by-同舟云学术

Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing

Published:2014-04-29 Issue:2 Volume:118 Page:405-412
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Kim Betty Y. S.,Jiang Wen,Beiko Jason,Prabhu Sujit S.,DeMonte Franco,Gilbert Mark R.,Sawaya Raymond,Aldape Kenneth D.,Cahill Daniel P.,McCutcheon Ian E.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-014-1451-0.pdf

Reference33 articles.

1. Stupp R, Tonn J, Brada M, Pentheroudakis G (2010) High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:190–193

2. Gupta T, Sarin R (2002) Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care. Lancet Oncol 3:557–564

3. Ryken T, Frankel B, Julien T, Olson JJ (2008) Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery. J Neurooncol 89:271–286

4. Tortosa A, Vinolas N, Villa S, Verger E, Gil JM, Brell M, Caral L, Pujol T, Acebes J, Ribalta T, Ferrer I, Graus F (2003) Prognostic implication of clinical, radiologic and pathologic features in patients with anaplastic gliomas. Cancer 97:1063–1071

5. Scott C, Nelson J, Farnan N, Curran W, Murray K, Fischbach A, Gaspar L, Nelson D (1995) Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group. Cancer 767:307–313

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups;The Lancet Oncology;2023-11

2. The role of [18F]fluorodopa positron emission tomography in grading of gliomas;Journal of Neuro-Oncology;2022-11-24

3. The Extent of Resection in Gliomas—Evidence-Based Recommendations on Methodological Aspects of Research Design;World Neurosurgery;2022-05

4. T2–Fluid-Attenuated Inversion Recovery Mismatch Sign in Grade II and III Gliomas: Is There a Coexisting T2–Diffusion-Weighted Imaging Mismatch?;Journal of Computer Assisted Tomography;2022-03

5. PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging;Frontiers in Oncology;2021-03-30